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Summary
Invariant natural killer T (iNKT) cell-derived cytokines
have important functions in inflammation, host de-
fense, and immunoregulation. Yet, when and how
iNKT cells undergo effector differentiation, which en-
dows them with the capacity to rapidly secrete cyto-
kines upon activation, remains unknown. We discov-
ered that granulocyte-macrophage colony-stimulating
factor (Csf-2)-deficient mice developed iNKT cells
that failed to respond to the model antigen a-galacto-
sylceramide because of an intrinsic defect in the fu-
sion of secretory vesicles with the plasma membrane.
Exogenous Csf-2 corrected the functional defect only
when supplied during the development of thymic,
but not mature, splenic Csf-2-deficient iNKT cells.
Thus, we ascribe a unique function toCsf-2, which reg-
ulates iNKT cell effector differentiation during devel-
opment by a mechanism that renders them competent
for cytokine secretion.
Introduction
Commitment and differentiation to the T cell lineage oc-
cur in the thymus from a pluripotent lymphocyte progen-
itor. T lineage consists predominantly of ab T cells and
a minor population of gd cells. Among the ab T cells
are the conventional CD4+ and CD8+ lymphocytes as
well as several minor subsets, including CD4+CD25+
Treg and NK1.1
+ natural killer T (NKT) cells. After commit-
ment at the CD4+CD8+ double-positive stage, the con-
ventional CD4+ and CD8+ lymphocytes mature and em-
igrate to peripheral lymphoid organs. Here, upon
antigen recognition, they undergo further maturation
by a process termed effector differentiation or functional
maturation. In conventional T cells, effector differentia-
tion requires chromatin remodeling and transcriptional
regulation of cytokine gene loci. Thus, effector differen-
tiation of conventional T cells is a postdevelopmental
event that occurs in peripheral lymphoid organs. How-
ever, very little is known regarding effector differentia-
tion of the remaining T cell subsets. Therefore, we
have focused the current study on the mechanism(s) un-
derlying effector differentiation of NKT cells.
Invariant NKT (iNKT) cells are unique T lineage cells
whose immunoregulatory functions depend on rapid cy-
tokine secretion (Van Kaer, 2005). Phenotypically, iNKT
cells represent an unusual hybrid between conventional
*Correspondence: sebastian.joyce@vanderbilt.eduT and natural killer (NK) cells, expressing both an invari-
ant Va14Ja18 T cell receptor (TCR) and several NK cell-
specific receptors (Van Kaer, 2005). Functionally, how-
ever, iNKT cells are distinct from these two lymphocyte
lineages. They recognize pathogen-induced, endoge-
nous (Brigl et al., 2003; Zhou et al., 2004) and patho-
gen-derived, exogenous (Kinjo et al., 2005; Mattner
et al., 2005; Sriram et al., 2005) glycolipid antigens
when presented in the context of CD1d molecules. Our
current understanding of iNKT cell function in vivo has
emerged from probing with a marine sponge-derived
synthetic glycolipid antigen, a-galactosylceramide
(aGC), that closely resembles a pathogen-derived
antigen, a-galacturonosylceramide (Kinjo et al., 2005;
Mattner et al., 2005; Sriram et al., 2005). These studies
revealed that iNKT cells might detect glycolipids gener-
ated during infection or tumorigenesis and rapidly relay
this information to other effector leukocytes. To accom-
plish this task, iNKT cells secrete copious amounts of ef-
fector cytokines as quickly as 30–60 min after activation
in vivo (Carnaud et al., 1999; Yoshimoto and Paul, 1994).
Interferon-g (IFN-g) secreted by activated iNKT cells
promotes antitumor immunity and immune responses
to pathogens or acts as a catalyst to facilitate T helper
1 (Th1) responses to peptide antigens (Fujii et al., 2003;
Hermans et al., 2003; Silk et al., 2004; Smyth et al., 2002).
Conversely, interleukin-4 (IL-4) secreted by in vivo acti-
vated iNKT cells promotes Th2 responses to peptide
antigens and together with IL-10 prevents the onset of
autoimmune disease in various animal models (Burdin
et al., 1999; Singh et al., 1999; Van Kaer, 2005). Thus, a
thorough appreciation of the immunoregulatory roles
of iNKT cells requires an in-depth understanding of
when and how this T subset acquires its unique effector
functions.
Unlike conventional T cells, naive thymic, splenic, and
hepatic iNKT cells have transcriptionally active Il4 and
Ifng gene loci (Matsuda et al., 2003; Stetson et al.,
2003). Even the NK1.12 thymic iNKT cells, which are pre-
cursors of all iNKT cells, transcribe and translate their Il4
locus (Benlagha et al., 2002; Gadue and Stein, 2002;
Matsuda et al., 2003; Pellicci et al., 2002; Stetson et al.,
2003). Therefore, we hypothesized that iNKT cells ac-
quire effector properties during thymic development at
the stage when they diverge into a distinct lineage
from conventional T lymphocytes. iNKT cell precursors
share the same early developmental stages with con-
ventional T cells. It is only after the assembly of their
unique TCR (Va14Ja18 paired with Vb8.2, Vb7, or Vb2)
and its positive selection by CD1d-expressing cortical
thymocytes that commitment toward this distinct line-
age occurs (Benlagha et al., 2005; Bezbradica et al.,
2005a; Egawa et al., 2005; Gapin et al., 2001). At this
time, a transcriptional program unique to iNKT cells is
initiated. Thus, deficiencies in several signaling mole-
cules and transcription factors (Ets, MEF, T-bet, SAP,
Fyn, Itk, PKC-q, Bcl-10, IKKb, and NF-kB) profoundly
impair iNKT cell ontogeny (Chung et al., 2005;
Eberl et al., 1999; Gadue et al., 1999; Gadue and Stein,
2002; Lacorazza et al., 2002; Pasquier et al., 2005;
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Stanic et al., 2004a, 2004b; Townsend et al., 2004; Walu-
nas et al., 2000). We recently discovered that iNKT cells
with a block in NF-kB signaling (IkBDN) failed to com-
plete their maturation program in the thymus, a defect
that can be fully corrected by overexpression of the anti-
apoptotic protein Bcl-xL (Stanic et al., 2004a). However,
we found that, despite full reconstitution of what ap-
pears to be phenotypically and molecularly mature
iNKT cells, Bcl-xL transgenesis did not restore iNKT
cell function (Stanic et al., 2004b). This finding suggests
that NF-kB signaling regulates not only survival but also
functional maturation of iNKT cells during ontogeny and,
hence, raises the question as to which NF-kB-regulated
gene(s) is responsible for functional maturation of iNKT
cells.
Previous studies have implicated granulocyte-macro-
phage colony-stimulating factor (Csf-2), an NF-kB-in-
duced protein (Thomas et al., 1997), in iNKT cell ontog-
eny. Csf-2 was shown to promote maturation of iNKT
cell precursors by enhancing Va14 to Ja18 recombina-
tion in an in vitro cell-culture system. Further, mice defi-
cient in the common b-chain (bc) receptor, which Csf-2
shares with IL-3 and IL-5, poorly develop iNKT cells
(Sato et al., 1999). Moreover, the cytokine-specific,
Csf-2 receptor-a (Csf-2Ra) chain signals through NF-
kB in human umbilical cord endothelial cells (Ebner
et al., 2003). For these reasons, we analyzed iNKT cell
development and function in Csf-2-deficient mice. Our
data highlight a previously unrecognized, instructive
role for Csf-2 in functional maturation of iNKT cells. Fur-
ther, they indicate that the acquisition of regulated se-
cretory function is a unique differentiation step toward
the generation of immunocompetent iNKT cells.
Results
iNKTCells Express Functional Csf-2R, which Signals
through NF-kB
Current evidence suggests that only myeloid cells ex-
press Csf-2R (Enzler and Dranoff, 2003). If Csf-2 regu-
lates iNKT cell ontogeny and effector differentiation,
this T subset should express functional Csf-2R and the
thymus should have a source for Csf-2. We found that
most thymic, splenic, and hepatic iNKT cells expressed
the Csf-2R, as did some conventional T cells, albeit at a
lower amount (Figure 1A). Further, thymocytes secreted
modest amounts of Csf-2 when activated ex vivo via
either aGC or by crosslinking CD3+CD28 molecules
(Figure 1B).
To determine whether the expressed Csf-2R is func-
tional, highly purified, unactivated primary iNKT cells
were required. Therefore, we developed a strategy for
sorting primary mouse iNKT cells without ligating any
of their stimulatory or inhibitory receptors. In brief, we
took advantage of 4get mouse in which the gene encod-
ing enhanced green fluorescent protein (eGFP) pre-
ceded by an internal ribosome entry sequence was
knocked in downstream of the Il4 locus (Stetson et al.,
2003). In naive 4get mice, the Il4-eGFP bicistronic tran-
script is highly restricted to NK1.12 and NK1.1+ iNKT
cells (Matsuda et al., 2003; Stetson et al., 2003; see
Figure S1A in the Supplemental Data available online).
Taking advantage of strong green fluorescence, naiveiNKT cells were isolated by fluorescence-activated cell
sorting (FACS). The iNKT cells isolated by this strategy
were >95% pure as determined by CD33andaGC-loaded
tetrameric mouse CD1d1 (tetramer) staining. They dis-
played all phenotypic properties of nonactivated iNKT
cells (Figure S1B). Further, they did not secrete any cyto-
kines or show other hallmarks of activation (TCR down-
modulation, data not shown) unless stimulated through
their TCR (Figure S1C). Thus, the iNKT cells isolated in
this manner were viable, functional, and remained quies-
cent through the entire purification process.
Recent studies show that Csf-2Ra chain signals
through NF-kB (Ebner et al., 2003). Because functional
maturation of iNKT cells requires signaling through
NF-kB (Stanic et al., 2004b), we determined whether
Csf-2R ligation with recombinant mouse (rm) Csf-2 acti-
vates NF-kB in purified iNKT cells. The data revealed that
Csf-2R ligation induced IkBa phosphorylation, which
could not be attributed to lipopolysaccharide (LPS) con-
tamination (Figure 1C). Thus, iNKT cells expressed func-
tional Csf-2R in terms of its signaling through NF-kB
pathway. Hence, Csf-2 may play a role in functional
iNKT cell ontogeny.
Csf-2-Deficient iNKT Cells Are Functionally Impaired
We next determined whether Csf-2 signaling through its
cognate receptor is essential for the development of
functional iNKT cells. We found that Csf-2-deficient
mice developed mature iNKT cells. Their numbers
were w85%–95% of those observed in wild-type (wt)
thymus, spleen, and liver (Figures 2A and 2B). Detailed
characterization revealed that Csf-2 was not essential
for phenotypic (NK1.1, DX5, HSA, CD5, CD44, CD69,
CD122, CD127, Ly49A) or molecular (Bcl-2, IL-4, IFN-g)
maturation of developing iNKT cells (data not shown).
It was also not required for their survival and prolifera-
tion (data not shown). Thus, in contrast to the previous
report (Sato et al., 1999), Csf-2 appears to be dispens-
able for the generation of iNKT cells.
We found that Csf-2-deficient mice elicited unusually
small amounts of cytokines upon stimulation in vivo
with aGC (Figure 2C) or in vitro with anti-CD33+CD28
Abs (Figure S2A). Delayed kinetics of cytokine secretion
by Csf-2-deficient iNKT cells was unlikely, because Csf-
2-deficient splenocytes did not respond to aGC even af-
ter 4 days of in vitro stimulation (Figure 2D). Further, the
lack of cytokine response in vivo was not due to the lack
of antigen recognition and stable cell-cell interaction
with antigen-presenting cells (APCs), because early fea-
tures of glycolipid presentation and recognition, such as
TCR downmodulation on iNKT cells (Figure S2B) and
CD86 upregulation on APCs (Figure S2C), were intact.
Importantly, late, cytokine-dependent functions of iNKT
cells, such as transactivation of B, CD8+ T, and NK cells
(Figures S2D and S2E), were severely impaired.
In additional experiments, we found that Csf-2-defi-
cient NK but not iNKT cells secreted IFN-g in response
to phorbol myristate acetate (PMA)+ionomycin as well
as IL-12, IL-18, and IL-12+IL-18 (Figures S2A and S2F).
Similarly, Csf-2-deficient CD8+ T cells secreted IFN-g
in response to minor histocompatibility (minor H) anti-
gens (Figure S2G), MHC alloantigens, TCR+CD28 liga-
tion, and PMA+ionomycin (Wada et al., 1997). Moreover,
as described later, Csf-2-deficient dendritic cell (DC)
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(A) Cells were permeabilized and reacted with Csf-2Ra cytoplasmic tail-specific Ab (open histograms) or isotype control (gray histograms) and
detected with anti-rabbit Ig-FITC. iNKT cells (red), T cells (green), NK cells (blue), and splenic DCs (black) were identified as CD3+tetramer+,
CD3+tetramer2, CD32NK1.1+, and CD11c+ cells, respectively, within electronically gated CD8lo thymocytes, B220lo spleen, or liver cells.
(B) Thymocytes from C57BL/6 and Csf-2-deficient mice were stimulated for 30 hr with either aGC or anti-CD33+CD28 Abs. Secreted Csf-2 was
measured by ELISA. Representative of two independent experiments; bars indicate mean 6 standard error of mean (SEM).
(C) Purified thymic 4get iNKT cells were activated with 100 ng/ml PMA and 2 mM ionomycin, 100 ng/ml rmCsf-2, or 100 ng/ml LPS. After 15 min,
total and phosphorylated IkBa were determined by immunoblot. Representative of three independent experiments.function also appeared normal with respect to glycolipid
antigen presentation. Together, these data indicate that
defective cytokine secretion is a hallmark of Csf-2-defi-
cient iNKT but not other cell lineages.The Functional Defect in Csf-2-Deficient iNKT
Cells Is Cell Intrinsic
Csf-2 is a myeloid growth and differentiation factor (En-
zler and Dranoff, 2003). Because DCs are myeloid cellsFigure 2. Csf-2-Deficient Mice Develop Functionally Impaired iNKT Cells
(A) Thymic, splenic, and hepatic iNKT cells from C57BL/6 and Csf-2-deficient mice were identified as CD3+tetramer+ cells within electronically
gated CD8lo thymic or B220lo spleen and liver cells. Numbers are % iNKT cells among total leukocytes. Representative of five independent
experiments.
(B) Absolute numbers of iNKT cells in thymus, spleen, and liver from C57BL/6 and Csf-2-deficient mice were calculated from % iNKT cells in (A)
and total cell count. Representative of five independent experiments; bars indicate mean 6 SEM.
(C) Serum cytokine response to in vivo activation of iNKT cells was measured after 2 (IL-2 and IL-4) and 6 (IFN-g) hours of 5 mg aGC or vehicle
injection. Cytokine response is plotted against average number of splenic iNKT cells determined in (B). To account for difference in absolute cell
number in C57BL/6 and Csf-2-deficient mice, a diagonal was arbitrarily set from zero at the origin to C57BL/6 cytokine response. It represents
what would be equal to wt response per cell basis. Values on the left and right of it represent responses lower or higher than wt, respectively.
Background induced by vehicle was subtracted from specific aGC-induced responses. Data show mean of four independent experiments 6
SEM.
(D) Splenocytes from Ja182/2, Csf-22/2, or C57BL/6 mice were activated in vitro with 100 ng/ml aGC for 4 days. IL-4 secreted into the culture
supernatant after 1, 2, 3, or 4 days was measured by ELISA. Background was subtracted as in (C). One representative experiment of three
independent ones is shown; bars indicate mean of triplicate measurement for each condition.
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(A) Freshly purified, vehicle- or aGC-pulsed splenic DCs from C57BL/6 and Csf-2-deficient mice were adoptively transferred into C57BL/6 or Csf-
2-deficient mice, and serum IFN-g response was measured 6 hr later by ELISA. Representative of two independent experiments; bars indicate
mean 6 SEM.
(B) Purified (w95% purity) DCs from C57BL/6 and Csf-2-deficient mice were incubated in vitro with iNKT cell-enriched splenic fraction from
C57BL/6 or Csf-2-deficient mice at a ratio of 1:100 in the presence of aGC for 4 days. IFN-g and IL-4 responses from iNKT cells were measured
after 4 days. Background was subtracted as in Figure 2C. Representative of three independent experiments; bars indicate mean 6 SEM.critical for iNKT cell activation in vivo (Bezbradica et al.,
2005b; Schmieg et al., 2005), iNKT cell unresponsive-
ness could be the result of altered growth and/or differ-
entiation of Csf-2-deficient DCs. However, Csf-2-defi-
cient mice developed wt numbers of DCs, expressed
wt amounts of CD1d1 (Figure S3), and upregulated cos-
timulatory molecules upon initial interaction with acti-
vated iNKT cells (Figure S2C). Thus, Csf-2-deficient DCs
appear phenotypically mature. Next, we purified Csf-2-
deficient and wt DCs, pulsed them with aGC, and trans-
ferred them into Csf-2-deficient and wt recipients to test
their functional maturity. Both Csf-2-deficient and wt
aGC-pulsed DCs activated wt iNKT cells, but neither re-
constituted robust cytokine secretion when transferred
into Csf-2-deficient recipients (Figure 3A). Further, we
fully recapitulated the above results in more controlled,
in vitro conditions, where purified Csf-2-deficient or wt
DCs were cocultivated with iNKT cell-enriched Csf-2-
deficient or wt splenocytes in the presence of antigen
(Figure 3B). Thus, the functional defect in Csf-2-deficient
mice is intrinsic to iNKT cells but not DCs.
Effector Differentiation of iNKT Cells
Is Developmentally Regulated by Csf-2
The functional response to aGC in vivo is the result of
complex interactions between DCs and iNKT cells, in-
volving direct cell-cell communications and release of
soluble factors (Van Kaer, 2005). Thus, the lack of robust
cytokine response in Csf-2-deficient mice could reflect
the absence of peripheral Csf-2 essential for DC-iNKT
cell communication. However, provision of exogenous
rmCsf-2 at the time of aGC delivery did not reconstitute
the iNKT cell response in vivo (Figure 4A). Similarly, pro-
vision of rmCsf-2 during the entire course of in vitro stim-
ulation with aGC did not rescue defective Csf-2-defi-
cient iNKT cell function (Figure 4B). Note that 50, 100,
500, and 1000 ng Csf-2/mouse were tested and 100 ng
of Csf-2 appeared optimal for this response (data not
shown). The lack of cytokines in the culture medium
was not due to rapid utilization or degradation becausesurface cytokine capture assay did not detect IFN-g
after Csf-2-deficient iNKT cell activation (Figure 4C).
From the above data, we speculated that Csf-2 pro-
motes functional maturation of iNKT cells during ontog-
eny. Development of this lineage begins in postnatal thy-
mus (Benlagha et al., 2005). Thus, we developed an ex
vivo culture system with thymocytes derived from 3- to
21-day-old wt and Csf-2-deficient mice that were sup-
plemented with recombinant human (rh) IL-7 and/or
rhIL-15. We found that IL-7, IL-15, and IL-7+IL-15 ex-
panded iNKT cells in this assay (Figures S4A–S4C). Sup-
plementation of thymocyte cultures derived from 3- to
8-day-old but not 21-day-old or older mice with rmCsf-2
rescued cytokine response of Csf-2-deficient iNKT cells
(Figure 4C). This functional rescue may perhaps be due
to higher proportion of immature iNKT cells in 3- to
8-day-old but not in older thymocytes (Figure S4D).
These data indicate that functional responsiveness to
antigen is a property assumed during ontogeny that
cannot be acquired once iNKT cells have completed
their differentiation program in the thymus and have
populated the peripheral lymphoid organs.
Autocrine Regulation of Functional iNKT Cell
Ontogeny by Csf-2
Endothelial cells, stromal cells, macrophages, fibro-
blasts, NK cells, and activated T and iNKT cells can se-
crete Csf-2 in vivo (Enzler and Dranoff, 2003) and, hence,
are potential sources of Csf-2 during iNKT cell ontogeny.
To determine the source of Csf-2 that mediates func-
tional iNKT cell ontogeny, we prepared a series of recip-
rocal bone marrow (BM) chimeras with Csf-2-deficient
and Ja18-deficient (which develop conventional T cells
but not iNKT cells [Cui et al., 1997]) mice. Because
Csf-2+/+/Csf-22/2 and Csf-2+/+/Csf-2+/+ radiation
BM chimeras developed iNKT cells (Figure 5A) and re-
constituted function (Figure 5B), we concluded that he-
matopoietic cell-derived Csf-2 mediates iNKT cell matu-
ration. Thus, both conventional T and iNKT cells could
be the source of thymic Csf-2 that promotes effector
Effector Differentiation of iNKT Cells by Csf-2
491Figure 4. Administration of Csf-2 during Development but Not in the Periphery Rescues iNKT Cell Function
(A) C57BL/6, Csf-2-, and CD1d1-deficient mice were injected i.p. with vehicle or 5 mg aGC6 100 ng of Csf-2. After 2 hr, serum IL-4 was measured
by ELISA. Representative of two independent experiments; bars indicate mean 6 SEM.
(B) Splenocytes from C57BL/6, Csf-2-, and CD1d1-deficient mice were stimulated with 100 ng/ml aGC+Csf-2 for 4 days. IL-4 and IFN-g secreted
by activated iNKT cells were measured by ELISA after 1, 2, 3, and 4 days. Representative results from 2-day culture are shown (left). Splenocytes
from C57BL/6, Csf-2-deficient mice were similarly stimulated for 24 hr, and secreted IFN-g was captured and detected by ELIspot assay (right).
Representative of two independent experiments performed in triplicates; bars indicate mean 6 SEM.
(C) Thymocytes from 3- to 21-day-old mice were cultivated for 14 days in vitro in the presence of 10 ng/ml rhIL-7, 100 ng/ml rhIL-15, and/or 100
ng/ml rmCsf-2. After 14 days, thymic cultures were stimulated overnight with vehicle- or aGC-loaded DCs in 1:100 DC:thymocyte ratio and se-
creted cytokines were monitored. Note that rhIL-7, rhIL-15, and rmCsf-2 were kept in cultures during the entire stimulation procedure. One rep-
resentative experiment of two independent ones is shown; bars indicate mean of triplicate measurement for each condition.differentiation of iNKT cells. To identify the source of
thymic Csf-2, we generated mixed Csf-22/2+Ja182/2/
Csf-22/2 and Csf-22/2+Ja182/2/Ja182/2 BM chi-
meras. In this system, Ja182/2 BM should be a source
of T cell-derived Csf-2. We found that the mixed BM chi-
meras did not reconstitute iNKT cell function (Figure 5B).
Note that all chimeras successfully reconstituted iNKT
cell numbers (Figure 5A) as well as early features of
glycolipid antigen recognition, as measured by CD69
upregulation on aGC-activated chimeric iNKT cells (Fig-
ure 5C). Thus, Csf-2 plays a cell-autonomous role in
iNKT cell effector differentiation.
Csf-2 Controls the Acquisition of Secretory Function
in iNKT Cells
Next, we investigated the mechanism by which Csf-2 in-
structs iNKT cell effector differentiation. The response of
iNKT cells to antigen results in immediate translation of
preformed cytokine mRNA and rapid cytokine secretion
(Matsuda et al., 2003; Stetson et al., 2003) and prolifera-
tion (Crowe et al., 2003; Wilson et al., 2003) in vivo and
ex vivo. Csf-2-deficient iNKT cells proliferated efficiently
to antigen ex vivo (Figure S5A), suggesting that proximal
TCR signaling is intact. Thus, the defect in Csf-2-
deficient iNKT cells might reflect a block in cytokine tran-
scription, translation, and/or secretion. Transcription ofcytokine genes in Csf-2-deficient iNKT cells appeared
unaffected because 4get Csf-2-deficient iNKT cells have
similar eGFP expression as wt 4get iNKT cells (Fig-
ure S1A). To distinguish between the remaining two pos-
sibilities, iNKT cells were activated by aGC in vivo or
in vitro and intracellular IL-4 and IFN-g were monitored.
We found that Csf-2-deficient iNKT cells expressed wt
amounts of intracellular IL-4 and IFN-g in response to
aGC in vivo (Figure 6A) and in vitro (Figure 6B). Yet,
Csf-2-deficient iNKT cells failed to secrete these cyto-
kines into the serum (Figure 2C) and the culture superna-
tant (Figure S5B). Similar results were obtained when
wt and Csf-2-deficient iNKT cells were activated in vitro
with PMA+ionomycin (Figure S5C). Thus, we conclude
that cytokine transcription and translation are intact
whereas secretion is impaired in Csf-2-deficient iNKT
cells.
Csf-2-Deficient iNKTCells HaveDefects in the Fusion
of Secretory Vesicles with the Plasma Membrane
Current evidence suggests that cytokine-containing
vesicles, akin to cytolytic granules (Bossi and Griffiths,
2005), are polarized toward the immune synapse prior
to release by activated T cells (Morales-Tirado et al.,
2004). Therefore, to test whether cytokine polarization
is intact, freshly purified wt and Csf-2-deficient splenic
Immunity
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(A) Radiation BM chimeras were generated as indicated, and 8 weeks after transplantation, iNKT cell numbers were monitored in the thymus,
spleen, and liver. Numbers within plots represent % iNKT cells among total lymphocytes. Representative of two independent experiments.
(B) 8 weeks after radiation, BM chimeras were generated and mice were injected with 5 mg aGC or vehicle i.p. and analyzed as described in
Figure 2C. Data show mean of three independent experiments 6 SEM.
(C) 8 weeks after transplantation, chimeras were injected i.p. with vehicle (gray histograms) or 5 mg aGC (open histograms). After 2 hr, CD69 up-
regulation was monitored on gated CD3+tetramer+ splenic iNKT cells. Numbers within plots represent % CD69+ iNKT cells. Representative of two
independent experiments.iNKT cells were activated ex vivo with aGC-pulsed wt
DC. iNKT cell-DC conjugates were visualized by confo-
cal microscopy. Strikingly, Csf-2-deficient iNKT cells
were just as fast and successful in polarizing corticalactin and IFN-g to the plasma membrane at the site of
the immune synapse as were their wt counterparts
(Figure 7A). Thus, the early features of the regulated se-
cretory pathway, i.e., formation and polarization ofFigure 6. Csf-2 Controls Development of
Rapid Cytokine Secretion by Activated iNKT
Cells
(A) Csf-2+/2 and Csf-22/2 mice were injected
i.p. with 5 mg aGC (open histograms) or vehi-
cle (gray histograms). After 2 hr, B220loCD3+
tetramer+ cells were electronically gated and
intracellular IFN-g (top), and IL-4 (bottom) ex-
pression was monitored. Numbers refer to
MFI. Representative of three independent ex-
periments. Numbers represent MFI.
(B) Splenocytes from Csf-2+/2 and Csf-22/2
mice were incubated with vehicle (gray histo-
grams) or 100 ng/ml ofaGC (open histograms)
for 5 days. CD3+tetramer+ iNKT lymphocytes
were identified and analyzed as described in
(A). Representative of two independent ex-
periments. Numbers represent geometric
MFI.
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(A) Purified, splenic iNKT cells from 4get;Csf-2+/2 or 4get;Csf-22/2 mice were stimulated with vehicle- (rows 1 and 4) or aGC- (rows 2 and 3)
pulsed DC as described in Experimental Procedures. Cells were adhered to cover slips, fixed, made permeable, and reacted with IFN-g-Alexa647
Ab and phalloidin-rhodamine. Images were visualized by confocal microscopy. z axis image reconstitution over the iNKT cells-DC contact area
are far right. Representative images obtained from three independent experiments are shown.
(B) Splenocytes from Csf-2+/2 and Csf-22/2 mice were cultivated with vehicle (gray histograms) or 100 ng/ml aGC (open histograms). iNKT
cells were identified as B220loCD3+tetramer+ cells and cell-surface Lamp-1 expression determined. Representative of three independent
experiments.cytokine-containing vesicles, are intact in Csf-2-defi-
cient iNKT cells.
The final release of cytokines from the secretory ves-
icles requires fusion of the vesicular and plasma mem-
branes. This is a tightly regulated, signal-dependent
process (Bossi and Griffiths, 2005). We hypothesized
that the fusion of secretory vesicles with the plasma
membrane is blocked in Csf-2-deficient iNKT cells. In
conventional T lymphocytes, secretory vesicles express
lysosomal markers: e.g., Lamp-1, which is normally not
found on the cell surface, but appears there transiently
upon T cell activation (Peters et al., 1991), an event
that can be visualized by flow cytometry of intact cells.
Thus, wt and Csf-2-deficient splenocytes were incu-
bated in vitro with aGC, and Lamp-1 expression on
gated tetramer+ cells was monitored at different times.
We found that, although virtually all wt iNKT cells ex-
posed Lamp-1 on the cell surface shortly upon activa-
tion (Figure 7B), only a few Csf-2-deficient iNKT cells
did so (Figure 7B), despite similar expression patterns
of cell surface (Figure S6A) and intracellular (Figure S6B)
Lamp-1 on naive wt and Csf-2-deficient iNKT cells. This
lack of cell-surface Lamp-1 expression on activated
Csf-2-deficient iNKT cells was consistent with the inabil-
ity of these cells to secrete cytokines. Thus, the cytokine
secretion defect in Csf-2-deficient iNKT cells results
from the failure to fuse cytokine-containing secretory
vesicles with the plasma membrane.
Discussion
Csf-2 is generally recognized as a myeloid growth factor
in vitro (Enzler and Dranoff, 2003). Nonetheless, Csf-2
deficiency does not impair myelopoiesis (Dranoff et al.,
1994; Stanley et al., 1994), suggesting compensatory
roles for other myelopoietic factors. Here we have de-scribed a previously unrecognized role for Csf-2 in the
immune system, i.e., Csf-2 is critical for the effector dif-
ferentiation of iNKT cells. Therefore, Csf-2 deficiency
during thymic ontogeny results in the generation of
iNKT cells that acquire all the attributes of a mature T
lymphocyte, yet fail to secrete lineage-specific cyto-
kines. This finding highlights the acquisition of cytokine
secretory function as a terminal differentiation step to-
ward the generation of immunocompetent iNKT cells.
iNKT cells share several properties common to NK
and conventional T cells. Notwithstanding these similar-
ities, functions of iNKT, NK, and conventional T cells in
the immune system are distinct, suggesting that effector
differentiation of these cells might require distinct sig-
naling mechanisms. In support of this idea, T-box tran-
scription factor eomesodermin is known to promote ef-
fector differentiation of CD8+ T and NK, but not CD4+ T
or iNKT cells (Intlekofer et al., 2005; Pearce et al., 2003;
Townsend et al., 2004). Therefore, whether effector dif-
ferentiation is uniquely regulated in the iNKT cell lineage
hitherto remained an unanswered question. Our data
suggest that Csf-2 is an iNKT cell lineage-specific effec-
tor differentiation signal because Csf-2 deficiency did
not alter conventional T or NK cell functions.
Effector differentiation is a process by which commit-
ted cells acquire their unique functional properties. It
entails unique gene activation programs as observed
during Th1 versus Th2 differentiation, translational
regulation as seen in NK cells, and, in certain immune
cells, the final act of effector molecule release (e.g.,
mast cells and eosinophils). Effector differentiation
of conventional T cells occurs in the periphery upon
antigen encounter and, hence, is a postdevelopmental
process. In contrast, we found that effector differentia-
tion of iNKT cells regulated by Csf-2 is an ontogenetic
process, perhaps because their first encounter with
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occurs within the thymus itself (Zhou et al., 2004).
Thus, in contrast to conventional T cells, iNKT cell Il4
and Ifng gene loci are transcriptionally active shortly af-
ter lineage commitment and positive selection (Matsuda
et al., 2003; Stetson et al., 2003), suggesting that iNKT
cell effector function is posttranscriptionally regulated.
NK1.12 iNKT cells have already acquired the capacity
to secrete IL-4 upon agonistic ligation of their TCR (Ben-
lagha et al., 2002; Pellicci et al., 2002). Our data indicate
that Csf-2-deficient thymic and splenic iNKT cells do not
secrete IL-4 to agonistic signals, suggesting that (1)
iNKT cell effector differentiation occurs at an early
stage, shortly after lineage commitment and positive se-
lection, and (2) the acquisition of secretory function reg-
ulated by Csf-2 is a terminal step during iNKT cell effec-
tor differentiation. Such tight, multilevel regulation of
iNKT cell effector function might have evolved to protect
this autoreactive, innate lymphocyte against overt reac-
tivity and activation-induced negative selection in the
thymus. In addition, this mechanism may have evolved
to prevent overt reactivity of peripheral iNKT cells to
CD1d-expressing cells that display iGb3.
Reciprocal BM chimera experiments demonstrated
that Csf-2 functions in an iNKT cell-intrinsic manner.
We previously discovered that inhibition of NF-kB sig-
naling blocks iNKT cell ontogeny at an immature stage
due to the lack of survival signals (Stanic et al., 2004a).
Surprisingly, we found that Bcl-xL transgenesis, which
fully reconstitutes what appears to be mature iNKT cells,
does not restore iNKT cell function (Stanic et al., 2004b).
This finding suggests that NF-kB signaling not only reg-
ulates survival but also functional maturation of iNKT
cells. Importantly, Csf-2 is an NF-kB-regulated gene
(Thomas et al., 1997), and as demonstrated here, Csf-2
partially acts by activating NF-kB. Moreover, 4get trans-
gene introgressed into both IkBDN and Csf-2-deficient
mice yield iNKT cells that fluoresce green due to eGFP
expression. Therefore, NF-kB and Csf-2 signaling are
dispensable for transcription of the Il4 locus. Nonethe-
less, only Csf-2 but not IkBDN (Stanic et al., 2004b)
iNKT cells translate the Il4 transcript. Therefore, we pro-
pose a working model in which NF-kB controls func-
tional maturation of iNKT cell precursors by inducing
at least two regulators. The first, identified here as Csf-2,
regulates cytokine secretion and the second one, yet
to be identified, regulates translation of pretranscribed
cytokine mRNA.
Our first glimpse of the iNKT cell-DC synapse reveals
that Csf-2 deficiency prevents cytokine release from
mature iNKT cells. Therefore, signals emanating from
the Csf-2R could be acting on molecules essential for
cellular secretion. Within lymphocytes, signal-induced
secretion of cytolytic molecules appears to follow the
principles of regulated secretion akin to neurotransmit-
ters and hormones (Bossi and Griffiths, 2005; Burgoyne
and Morgan, 2003). Secreted molecules packed into
vesicles are transported to the synapse, via actin and
tubulin cytoskeleton, where vesicles dock at the plasma
membrane. Upon receiving agonistic signals, fusion of
the secretory and plasma membrane lipid bilayers
occurs, resulting in rapid release of the bioactive content
into the exocytic space (Morales-Tirado et al., 2004;
Murray et al., 2005). Our data place the Csf-2-dependentstep at the terminal stage of this complex process. Csf-2-
deficient iNKT cells synthesize cytokines and polarize
them toward the immune synapse, yet fail to secrete
them due to an intrinsic defect in the fusion of secretory
vesicles with the plasma membrane. Because activated
Csf-2-deficient iNKT cells polarize cortical actin and
cytokine-containing vesicles toward the immune syn-
apse, it is unlikely that WASp, Arp2/3, dynamin, and
Rab27a, molecules required for vesicle polarization (Bur-
goyne and Morgan, 2003), mediate Csf-2 action. More-
over, we demonstrated that exogenous Csf-2 provided
to activated, peripheral Csf-2-deficient iNKT cells does
not restore secretion. Together, these data suggest
that Csf-2 is unlikely to act as a direct activation signal
for the assembly of the fusion complex. Instead, Csf-2
mediates its activity during ontogeny, as demonstrated
here, by either inducing de novo synthesis of protein(s)
required for vesicular fusion or by signaling their proper
subcellular localization. The nature of the Csf-2-induced
factor that regulates secretion and whether it is iNKT cell
lineage specific currently remain unanswered questions.
In summary, in studies directed toward understanding
when and how iNKT cells attain functional competence,
we discovered that Csf-2 plays a novel, critical role in the
effector differentiation of these cells. Csf-2 acts at the
early thymic iNKT cell precursor stage after lineage
commitment and positive selection by regulating the
acquisition of secretory function for synapse-directed
release of key immunoregulatory cytokines.
Experimental Procedures
Mice
C57BL/6, 129/SvJ, BALB/c-4get (4get), and B6.129-IL-42/2 (IL-42/2)
were purchased from the Jackson Laboratory. B6.129-CD1d12/2
(CD12/2) and B6.129-Ja182/2 (Ja182/2) mice have been described
(Cui et al., 1997; Mendiratta et al., 1997). B6.129-Csf-22/2 (Csf-22/2)
mice (Stanley et al., 1994), generously provided by Dr. L.J. Old
(Ludwig Institute for Cancer Research, NY), were generated by
backcrosses to C57BL/6 for 5–6 generations. For sorting of iNKT
cells, 4get mice were backcrossed once with Csf-2-deficient mice
and the F1 animals were intercrossed; Csf-2+/+, Csf-2+/2, and
Csf-22/2 littermates were used for experiments. All mouse experi-
ments complied with Vanderbilt’s IACUC regulations.
Antibodies and Reagents
All Abs, recombinant cytokines, ELISA, cell-surface, and intracellu-
lar staining reagents were from BD Pharmingen (Bezbradica et al.,
2006), unless stated otherwise. Purified Csf-2Ra-, IkBa- (Santa
Cruz Biotechnologies), phospho-IkBa- (Cell Signaling Technologies)
specific Abs, anti-rabbit Ig-Alexa 670 (Invitrogen), anti-mouse Ig-
IRDye (Rockland Immunochemicals), rhodamine-phalloidin (Invitro-
gen), and streptavidin-rhodamine (Jackson Immunoresearch Labo-
ratories) were purchased from the indicated sources. Kirin Brewery
Company (Gunma, Japan) generously provided aGC. Preparation
and use of tetramer are described elsewhere (Bezbradica et al.,
2006).
Flow Cytometry
Splenocytes of individual, age (6–10 weeks)-matched mice treated
with aGC or vehicle (0.1% Tween 20 in PBS) as control were stained
for four-color flow cytometric analysis. Abs and procedures are
described elsewhere (Bezbradica et al., 2006). iNKT cells were
identified as CD3+tetramer+ cells among B220lo splenocytes and he-
patocytes or CD8lo thymocytes. Four-color flow cytometry was per-
formed with a FACSCalibur instrument (Becton Dickinson), and the
data were analyzed with FlowJo software (Treestar Inc.). Absolute
iNKT cell numbers were calculated from % tetramer+ cells and total
number of cells recovered from the organ. Standard error of mean
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root of n, where n equals sample size.
Intracellular Staining
Splenocytes from mice treated with aGC or vehicle control were
blocked with anti-CD16+CD32 (FcgIII/IIR). Cells were first stained
for CD33 and DX5 for NK cells or with anti-CD33 and tetramer for
iNKT cells, and then for IFN-g, IL-4, or the intracellular domain of
Csf-2Ra after fixing and permeabilizing with Cytofix+Cytoperm solu-
tion (BD Pharmingen) according to the manufacturer’s protocol.
Most experiments did not include brefeldin A in any of the steps. Ex-
periments with PMA+ionomycin 6 brefeldin A+monensin were per-
formed as described (Stanic et al., 2004b).
ELISA
Each mouse was injected i.p. with 5 mg of aGC or with vehicle as the
control. After 2, 4, and 6 hr, sera were collected and sandwich ELISA
was performed as described (Bezbradica et al., 2006).
CTL Priming and ELIspot Assay
C57BL/6 and Csf-2-deficient mice were immunized with w107 129
splenocytes in 0.1 ml PBS. A week later, 2.5 3 105 immune spleno-
cytes were stimulated with H2Kb-restricted peptides (H60
[LTFNYRNL], H4b [SGIVYIHL], or SV40 epitope IV [VVYDFLKL]
[Yoshimura et al., 2004]) in nitrocellulose microtitre plates (Millipore)
precoated with anti-IFN-g Ab (4 mg/ml). After 48 hr at 37C, plates
were washed with PBS containing 0.05% Tween and incubated
with biotinylated anti-IFN-g Ab (2 mg/ml; eBiosciences) for 4 hr at
37C. After washing, spots were developed by sequential incubation
with Vectastain ABC peroxidase (Vector Laboratories) and 3-amino-
9-ethyl carbazole (Sigma) and counted with ELISPOT Reader
(Zeiss).
Cell Sorting and Adoptive Transfer
Preparation of DCs
Splenic DCs were purified by auto-MACS sorting (Miltenyi Biotec)
and pulsed with 0.1–1 mg/ml of aGC overnight. After extensive
washes, 6–10 3 105 aGC-pulsed DCs were adoptively transferred
i.v. into C57BL/6 or Csf-2-deficient mice. Control mice received
the same number of vehicle-pulsed DCs. After 6 hr, cytokine
response was measured by ELISA.
Enrichment of iNKT Cells
Splenic iNKT cells were enriched as described elsewhere (Bezbrad-
ica et al., 2006); average iNKT cell enrichment was up tow15%.
Purification of iNKT Cells by FACS
Taking advantage of strong green fluorescence, naive, 4get (Mat-
suda et al., 2003; Stetson et al., 2003) iNKT cells were isolated by
FACS. 4get thymocytes were reacted with CD8a and splenocytes
with H2IAb, B220, CD8a, and CD11c-specific beads. Labeled cells
were removed with auto-MACS sorter and the negative fraction
was used immediately for FACS. Granular cells were electronically
gated out and eGFP+ cells from a lymphocyte gate were sorted un-
der low (20 psi) pressure at 4C with FACSAria (Becton Dickinson).
Purity of sorted cells was determined with tetramer and anti-CD33
Ab; purity ranged between 95% and 99%.
Generation of Radiation BM Chimeras
Chimeras were generated as described previously (Bezbradica
et al., 2005a) and analyzed 8 or more weeks after transplantation.
CFSE Dilution Assay
Freshly isolated C57BL/6 and Csf-2-deficient splenocytes were la-
beled with carboxy fluorescein succinimidyl ester (CFSE; Invitrogen)
and cultivated with 100 ng/ml aGC or vehicle. After 5 days, cells were
stained for B220 (B cells), CD33 (T and iNKT cells), and tetramer
(iNKT cells) and analyzed by flow cytometry.
Western Blot
Purified, primary iNKT cells were treated for 30 min with 1 mM epox-
omycin (Sigma) to inhibit proteasome activity prior to activation by
100 ng/ml PMA+2 mM ionomycin (Sigma), 100 ng/ml LPS (Sigma),
or 100 ng/ml rmCsf-2 (BD Pharmingen). After 15 min, addition of
chilled PBS stopped the reaction. Cells were solubilized in RIPA
buffer containing protease and phosphatase inhibitors. Proteinswere separated by SDS-PAGE and transferred onto nitrocellulose
membrane. Membrane was incubated with rabbit IkBa- and mouse
phospho-IkBa-specific Abs followed by anti-rabbit Ig-Alexa670 and
anti-mouse Ig-IRDye. Proteins were visualized by infrared imaging
(Odyssey, LI-COR).
Csf-2 Complementation Experiments
Ex Vivo Thymic Csf-2 Complementation
Thymocytes of 2- to 42-day-old mice were cultivated for 14 days in
vitro in the presence of 10 ng/ml rhIL-7, 100 ng/ml rhIL-15, and 100
ng/ml rmCsf-2 (BD Biosciences) individually or in combination as in-
dicated. Cultures were supplemented with fresh medium and cyto-
kines every 2 days. After 14 days, thymic cultures were stimulated
overnight with vehicle- or aGC-loaded DCs in 1:100 DC:thymocyte
ratio. Secreted cytokines were monitored in culture supernatant by
ELISA.
In Vivo Csf-2 Complementation
Doses of 50–1000 ng of rmCsf-2 were coinjected with aGC into 6- to
8-week-old C57BL/6 or Csf-2-deficient mice. After 2, 4, and 6 hr,
sera were collected for ELISA.
Ex Vivo Splenic Csf-2 Complementation
Splenocytes were cultivated in vitro with 10–500 ng/ml aGC 6 100
ng rmCsf-2 for 5 days. Every 24 hr, 100 ml of supernatant was col-
lected for ELISA.
Confocal Microscopy
Splenic iNKT cells from 4get;Csf-2+/2 or 4get;Csf-22/2 mice were
purified by FACS and expanded in vitro for 3–5 days in the presence
of 10 ng/ml rhIL-7 and 100 ng/ml rhIL-15. iNKT cells (w1–2 3 106)
were stimulated with w104 vehicle- or aGC-pulsed DCs in suspen-
sion for 30 min at 37C to form conjugates, layered over poly-L-
lysine-coated glass cover slips, and incubated for an additional
20–30 min to adhere. Cells were fixed with 3.7% paraformaldehyde
for 10 min at room temperature (RT). After washes with PBS, cells
were made permeable for intracellular staining and reacted with
anti-IFN-g-Alexa647 (BD Pharmingen) and phalloidin-rhodamine.
After 1 hr at RT, cells on cover slips were fixed with 2% paraformal-
dehyde for 10 min and washed. The cover slips were mounted on
slides and sealed with Aqua PolyMount (Polysciences, Inc.). Images
were viewed with 633 oil objective on LSM 510 META inverted con-
focal microscope and captured with Zeiss LSM Image software.
About 20–30 images per sample were scored per experiment. z-
axis image reconstitution of the iNKT cell-DC contact area was visu-
alized with Zeiss LSM5 Image Examiner Software.
Supplemental Data
Six Supplemental Figures can be found with this article online at
http://www.immunity.com/cgi/content/full/25/3/487/DC1/.
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